Valeant (VRX), DepoMed (DEPO) Sue Watson (WPI) Over Generic Glumetza
Bloomberg reporting Valent Pharma (NYSE: VRX) and DepoMed (Nasdaq: DEPO) have sued Watson (NYSE: WPI), challenging the company's generic glumetza product.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Depomed (DEPO) Issues Response to Starboard; Surprised About Public Solicitation Plans
- Vanda Pharmaceuticals (VNDA) sNDA for Fanapt Approved by U.S. FDA for Schizophrenia
- General Motors (GM) Enters $14.5B Revolver
Create E-mail Alert Related CategoriesCorporate News, Litigation
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!